André Delhon

858 total citations
32 papers, 710 citations indexed

About

André Delhon is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, André Delhon has authored 32 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in André Delhon's work include Cholesterol and Lipid Metabolism (10 papers), Lipoproteins and Cardiovascular Health (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). André Delhon is often cited by papers focused on Cholesterol and Lipid Metabolism (10 papers), Lipoproteins and Cardiovascular Health (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). André Delhon collaborates with scholars based in France, Germany and Japan. André Delhon's co-authors include Didier Junquéro, Françis C. Colpaert, Jean‐François Patoiseau, Yves Rival, Mylène Pezet, Oneil Lee, Stephen C. Strom, Naomi Sakashita, Robert V. Farese and Ellen T. Chang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

André Delhon

31 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Delhon France	14	363	271	138	129	101	32	710
Alain Vérine France	15	461 1.3×	165 0.6×	221 1.6×	79 0.6×	57 0.6×	46	759
Mark T. Yates United States	13	204 0.6×	170 0.6×	94 0.7×	69 0.5×	116 1.1×	19	731
J. Polonovski France	17	483 1.3×	238 0.9×	131 0.9×	164 1.3×	185 1.8×	86	1.0k
M E Pape United States	12	422 1.2×	323 1.2×	102 0.7×	96 0.7×	149 1.5×	18	758
Michael E. Pape United States	13	348 1.0×	299 1.1×	100 0.7×	97 0.8×	137 1.4×	24	708
Jayraz Luchoomun United States	13	280 0.8×	346 1.3×	132 1.0×	103 0.8×	63 0.6×	17	764
Patricia Foxworthy United States	14	513 1.4×	315 1.2×	88 0.6×	95 0.7×	131 1.3×	21	849
Christine L. Webb United States	11	260 0.7×	220 0.8×	111 0.8×	59 0.5×	74 0.7×	16	643
Chandrahasa R. Yellaturu United States	13	521 1.4×	286 1.1×	137 1.0×	205 1.6×	143 1.4×	15	949
Marc Issandou France	15	489 1.3×	219 0.8×	89 0.6×	49 0.4×	72 0.7×	24	850

Countries citing papers authored by André Delhon

Since Specialization

Citations

This map shows the geographic impact of André Delhon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Delhon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Delhon more than expected).

Fields of papers citing papers by André Delhon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Delhon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Delhon. The network helps show where André Delhon may publish in the future.

Co-authorship network of co-authors of André Delhon

This figure shows the co-authorship network connecting the top 25 collaborators of André Delhon. A scholar is included among the top collaborators of André Delhon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Delhon. André Delhon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pignier, Christophe, et al.. (2007). Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current. Basic Research in Cardiology. 102(6). 553–564. 35 indexed citations

Pilon, Antoine, Geneviève Martin, Didier Junquéro, et al.. (2003). Regulation of the scavenger receptor BI and the LDL receptor by activators of aldosterone production, angiotensin II and PMA, in the human NCI-H295R adrenocortical cell line. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1631(3). 218–228. 30 indexed citations

Wurch, Thierry, Didier Junquéro, André Delhon, & Petrus J. Pauwels. (2002). Pharmacological analysis of wild-type α, γ and δ subtypes of the human peroxisome proliferator-activated receptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 365(2). 133–140. 27 indexed citations

Rival, Yves, et al.. (2002). Anti-Atherosclerotic Properties of the Acyl-coenzyme A:Cholesterol Acyltransferase Inhibitor F 12511 in Casein-Fed New Zealand Rabbits. Journal of Cardiovascular Pharmacology. 39(2). 181–191. 18 indexed citations

Milliat, Fabien, Jacqueline Férézou, André Delhon, & Claude Lutton. (2001). Overexpression of SR-BI in hamsters treated with a novel ACAT inhibitor (F12511). Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 324(3). 229–234. 7 indexed citations

Junquéro, Didier, Antoine Pilon, Jean‐François Patoiseau, et al.. (2001). Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture11Abbreviations: ACAT, acyl-coenzyme A: cholesterol O-acyltransferase; F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide; DMEM, Dulbecco’s modified Eagle medium; FBS, fetal bovine serum; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SR-BI, scavenger receptor class B, type I; P450scc, cytochrome P450 cholesterol side-chain cleavage; P450c17, cytochrome P450 17 α-hydroxylase; P450c21, cytochrome P450 21-hydroxylase; PMA, phorbol 12-myristate 13-acetate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; cAMP, adenosine 3′5′-cyclic monophosphate; ITS, insulin-transferrin-linoleic acid; and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.. Biochemical Pharmacology. 61(4). 387–398. 18 indexed citations

Junquéro, Didier, et al.. (2001). Pharmacological profile of F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor. Biochemical Pharmacology. 61(1). 97–108. 27 indexed citations

Junquéro, Didier, et al.. (2001). F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. Atherosclerosis. 155(1). 131–142. 26 indexed citations

Chang, Catherine C.Y., Naomi Sakashita, Kim Ørnvold, et al.. (2000). Immunological Quantitation and Localization of ACAT-1 and ACAT-2 in Human Liver and Small Intestine. Journal of Biological Chemistry. 275(36). 28083–28092. 191 indexed citations

10.

Gotteland, Jean‐Pierre, et al.. (1998). Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells: A new type of potent squalene epoxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(11). 1337–1342. 12 indexed citations

11.

Gotteland, Jean‐Pierre, et al.. (1995). (Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors. Journal of Medicinal Chemistry. 38(17). 3207–3216. 27 indexed citations

12.

Delhon, André, et al.. (1995). Biochemical Changes and Morphological Alterations of Liver and Kidney in Hamsters after Administration of the HMG‐Coenzyme A Reductase Inhibitor, Simvastatin: Prevention and Reversibility by Mevalonate *. Pharmacology & Toxicology. 77(6). 391–396. 12 indexed citations

13.

Valentin, Jean‐Pierre, Françoise Grelac, Jacques Maclouf, et al.. (1995). Intrinsic activity of the non‐prostanoid thromboxane A₂receptor antagonist, daltroban (BM 13,505), in human plateletsin vitroand in the rat vasculaturein vivo. British Journal of Pharmacology. 115(1). 210–216. 7 indexed citations

14.

Tarayre, J.P., María J. Moreno‐Aliaga, Barbara Miziak, et al.. (1990). Antiallergic and Anti-Inflammatory Action of Tioxamast in Rats II.. International Archives of Allergy and Immunology. 92(1). 77–81. 1 indexed citations

15.

Tarayre, J.P., et al.. (1989). Pharmacological studies on zymosan inflammation in rats and mice. 1: Zymosan-induced paw oedema in rats and mice. Pharmacological Research. 21(4). 375–384. 30 indexed citations

16.

Tarayre, J.P., et al.. (1989). Pharmacological studies on zymosan inflammation in rats and mice. 2: Zymosan-induced pleurisy in rats. Pharmacological Research. 21(4). 385–395. 15 indexed citations

17.

Tarayre, J.P., André Delhon, María J. Moreno‐Aliaga, et al.. (1987). Pharmacological modulation of PAF-acether-induced pleurisy in rats. Pharmacological Research Communications. 19(12). 859–876. 5 indexed citations

18.

Cousse, Henri, et al.. (1987). Synthèse, structure et activité hypocholestérolémiante d'une série d'acides γ-aryl, γ-oxo butyriques substitués et dérivés. European Journal of Medicinal Chemistry. 22(1). 45–57. 6 indexed citations

19.

Delhon, André, et al.. (1977). The influence of various methods of sensitization on delayed hypersensitivity to Bordetella pertussis in the Sprague Dawley Rat.. PubMed. 228(1). 162–70. 3 indexed citations

20.

Delhon, André, et al.. (1977). Study of the repercussions on blood of acute experimental inflammation in rats. II. Blood changes in the course of carrageenin induced inflammation.. PubMed. 27(12). 2308–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact